Regulation of the human immune response in tuberculosis.
Tsuyuguchi
I
I
Osaka Prefectural Habikino Hospital, Japan.
D000818:Animals; D001500:BCG Vaccine / Q000276:immunology; D016516:CD4-CD8 Ratio; D015496:CD4-Positive T-Lymphocytes / Q000276:immunology; D018414:CD8-Positive T-Lymphocytes / Q000276:immunology; D006684:HLA-DR Antigens / Q000276:immunology; D006801:Humans; D006968:Hypersensitivity, Delayed / Q000382:microbiology; D007376:Interleukin-2 / Q000096:biosynthesis; D008213:Lymphocyte Activation; D051379:Mice; D008807:Mice, Inbred BALB C; D009000:Monocytes / Q000276:immunology; D015269:Mycobacterium avium Complex / Q000276:immunology; D009169:Mycobacterium tuberculosis / Q000737:chemistry / Q000276:immunology* / Q000472:pathogenicity; D016692:Receptors, Antigen, T-Cell, gamma-delta / Q000096:biosynthesis / Q000276:immunology; D014374:Tuberculin Test; D014397:Tuberculosis, Pulmonary / Q000276:immunology* / Q000517:prevention & control
D001500:BCG Vaccine; D006684:HLA-DR Antigens; D007376:Interleukin-2; D016692:Receptors, Antigen, T-Cell, gamma-delta